What is the 13F Pro Quality Score for CLNN?

13F Pro ranks Clene Inc. (CLNN) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CLNN's current score at https://13fpro.ai/company/CLNN (free sign-up required for the full ranking).

Where does 13F Pro source CLNN data?

All Clene Inc. fundamentals and ownership data come directly from SEC EDGAR. Clene Inc. files with the SEC under CIK 1822791. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CLNN in?

Clene Inc. (CLNN) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is CLNN research updated on 13F Pro?

CLNN's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Clene Inc.(CLNN)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1822791 CLNN stock profile & AI dashboard →

13F Pro Quality Score

10.1/100

Rank #2,912 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why CLNN Scores 10/100

exact factor attribution · 2026-09-11

CLNN's composite is driven by institutional flow, held back by revenue growth and scale. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Institutional flow

+1.6 pts

82th pct

Earnings quality

-0.2 pts

48th pct

Earnings growth

-2.2 pts

5th pct

Shareholder dilution

-2.5 pts

1th pct

Capital efficiency

-4.8 pts

2th pct

Free cash flow

-7.3 pts

1th pct

Profitability

-7.3 pts

1th pct

Scale

-7.3 pts

1th pct

Revenue growth

-9.7 pts

1th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

CLNN Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Clene Inc. (CLNN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CLNN at 10.1/100 on a 32-signal composite quality model, placing it at rank #2,912 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Clene Inc. reports quarterly revenue of $90.0K, net income of $-13.4M. Top institutional holders of CLNN by reported 13-F value include Empery Asset Management, SCOGGIN MANAGEMENT, Boxer Capital Management, based on the most recent SEC filings. CLNN trades on the Nasdaq exchange and files with the SEC under CIK 1822791. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CLNN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Clene Inc. directly from SEC EDGAR. Clene Inc.'s 13F Pro composite quality score has ranged between 7 and 12 since 2026, currently 10.1 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$90.0K

Net Income

Q2 2026

$-13.4M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-41.5% YoY

$200.0KFY 2025

FY22 $473.0KFY23 $654.0KFY24 $342.0KFY25 $200.0K

Net Income

+33.6% YoY

$-26.2MFY 2025

FY22 $-29.9MFY23 $-49.5MFY24 $-39.4MFY25 $-26.2M

Operating Income

+30.2% YoY

$-23.1MFY 2025

FY22 $-48.4MFY23 $-40.5MFY24 $-33.1MFY25 $-23.1M

Total Assets

-33.7% YoY

$18.1MFY 2025

FY22 $44.5MFY23 $52.3MFY24 $27.3MFY25 $18.1M

Total Debt

$17.8MFY 2025

FY22 —FY23 —FY24 —FY25 $17.8M

Op. Cash Flow

+13.0% YoY

$-18.5MFY 2025

FY22 $-39.0MFY23 $-30.2MFY24 $-21.3MFY25 $-18.5M

Free Cash Flow

+12.9% YoY

$-18.6MFY 2025

FY22 $-44.2MFY23 $-30.5MFY24 $-21.3MFY25 $-18.6M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$200.0K -41.5%	$342.0K -47.7%	$654.0K +38.3%	$473.0K -34.6%	$723.0K +251.0%	$206.0K
Net Income	$-26.2M +33.6%	$-39.4M +20.4%	$-49.5M -65.5%	$-29.9M -207.2%	$-9.7M +49.5%	$-19.3M
Operating Income	$-23.1M +30.2%	$-33.1M +18.4%	$-40.5M +16.3%	$-48.4M +3.1%	$-50.0M -147.2%	$-20.2M
Total Assets	$18.1M -33.7%	$27.3M -47.8%	$52.3M +17.6%	$44.5M -29.4%	$63.1M -7.6%	$68.2M
Total Debt	$17.8M	—	—	—	—	$5.9M
Operating Cash Flow	$-18.5M +13.0%	$-21.3M +29.3%	$-30.2M +22.7%	$-39.0M -12.7%	$-34.6M -82.9%	$-18.9M
Free Cash Flow	$-18.6M +12.9%	$-21.3M +30.0%	$-30.5M +31.0%	$-44.2M -22.9%	$-36.0M -86.1%	$-19.3M

Get alerted when CLNN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Clene Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CLNN

Empery Asset Management, LP
$5.6M916,532 sh
SCOGGIN MANAGEMENT LP
$3.7M600,000 sh
Boxer Capital Management, LLC
$2.9M477,515 sh
Ensign Peak Advisors, Inc
$2.1M348,062 sh
VANGUARD CAPITAL MANAGEMENT LLC
$2.1M333,706 sh
GEODE CAPITAL MANAGEMENT, LLC
$629.6K102,215 sh
BlackRock, Inc.
$378.9K61,559 sh
VANGUARD FIDUCIARY TRUST CO
$355.5K57,765 sh
Lunt Capital Management, Inc.
$321.7K52,260 sh
PARSONS CAPITAL MANAGEMENT INC/RI
$229.2K37,243 sh

Fund	Value	Shares
Empery Asset Management, LP	$5.6M	916,532
SCOGGIN MANAGEMENT LP	$3.7M	600,000
Boxer Capital Management, LLC	$2.9M	477,515
Ensign Peak Advisors, Inc	$2.1M	348,062
VANGUARD CAPITAL MANAGEMENT LLC	$2.1M	333,706
GEODE CAPITAL MANAGEMENT, LLC	$629.6K	102,215
BlackRock, Inc.	$378.9K	61,559
VANGUARD FIDUCIARY TRUST CO	$355.5K	57,765
Lunt Capital Management, Inc.	$321.7K	52,260
PARSONS CAPITAL MANAGEMENT INC/RI	$229.2K	37,243

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put CLNN on your watchlist

Track score changes the day Clene Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CLNN a good stock to buy?

13F Pro's AI-powered analysis of Clene Inc. (CLNN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CLNN are available on the CLNN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CLNN is classified as a small company.

Which hedge funds own CLNN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CLNN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Clene Inc.'s investment landscape.